003080 — Sungbo Chemical Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩57bn
- KR₩56bn
- KR₩63bn
- 21
- 56
- 22
- 20
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 45,710 | 36,978 | 39,098 | 30,590 | 19,245 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,894 | 2,776 | 3,582 | 5,147 | 5,588 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 94,101 | 82,772 | 90,108 | 87,306 | 82,854 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 42,076 | 42,629 | 42,317 | 41,357 | 42,772 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 172,441 | 159,210 | 172,157 | 170,785 | 165,627 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 16,565 | 12,982 | 26,951 | 24,401 | 24,801 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 25,813 | 22,541 | 36,353 | 33,237 | 32,846 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 146,629 | 136,669 | 135,803 | 137,548 | 132,781 |
Total Liabilities & Shareholders' Equity | 172,441 | 159,210 | 172,157 | 170,785 | 165,627 |
Total Common Shares Outstanding |